These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 5588884)
21. [Experiences with the new vasotherapeutic drug Trental in dermatology]. Herger R Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351 [No Abstract] [Full Text] [Related]
22. [Change in the microcirculatory indices in obliterative arterial diseases of the legs under the influence of pulse barotherapy]. Benin IuL; Kozlova LM; Perfil'ev AP Vopr Kurortol Fizioter Lech Fiz Kult; 1978; (2):80-1. PubMed ID: 654161 [No Abstract] [Full Text] [Related]
23. [Studies of the course of illness of arterial occlusion of the limbs]. Bollinger A; Lüthy E Helv Med Acta Suppl; 1966 May; 46():147. PubMed ID: 5286263 [No Abstract] [Full Text] [Related]
24. [Conservative therapy of obliterating diseases of the extremities]. Nazarov GD; Lesniak GP Khirurgiia (Mosk); 1970 Jan; 46(1):24-8. PubMed ID: 5437199 [No Abstract] [Full Text] [Related]
31. [Behavior of skin and muscle perfusions in chronic arterial occlusions associated with intermittent claudication with special reference to active exercise therapy. Studies using Hensel's fluvograph]. Koppelmann J Ergeb Chir Orthop; 1968; 51():9-27. PubMed ID: 4917699 [No Abstract] [Full Text] [Related]
32. [Treatment by hyperbaric oxygen of arteriopathies of the lower limbs. Apropos of 88 cases]. du Cailar J; Puech P; Serre L; Lefebvre F Sem Hop; 1968 Dec; 44(51):3150-4. PubMed ID: 4389817 [No Abstract] [Full Text] [Related]
34. METHODS FOR THE ANALYSIS OF THE BLOOD FLOW THROUGH THE LOWER EXTREMITIES IN OBLITERATIVE ARTERIAL DISEASES. PERNOW B Scand J Clin Lab Invest; 1963; 15():SUPPL 76:57-60. PubMed ID: 14163760 [No Abstract] [Full Text] [Related]
35. Sympathectomy in the treatment of occlusive arterial disease. Thulesius O; Gjöres JE Vasa; 1973; 2(2):132-8. PubMed ID: 4702338 [No Abstract] [Full Text] [Related]
36. [Conservative treatment of arteriosclerosis obliterans]. Thiele P Z Gesamte Inn Med; 1979 May; 34(9):99-102. PubMed ID: 483943 [TBL] [Abstract][Full Text] [Related]
37. [Anatomopathology and physiopathology of atherosclerosis obliterans of lower limbs]. Grosgogeat Y; Gratadour C Rev Prat; 1972 Nov; 22(29):3965-74. PubMed ID: 4649022 [No Abstract] [Full Text] [Related]
38. [On the therapy of peripheral organo-angiopathies using Progresin]. Horn HJ Med Klin; 1968 Aug; 63(35):1377-8 passim. PubMed ID: 5682033 [No Abstract] [Full Text] [Related]
39. [Considerations on the therapeutic indications in chronic obliterating arterial diseases of lower limbs]. De Maertelaere P Angeiologie; 1970; 22(3):179-90. PubMed ID: 5427841 [No Abstract] [Full Text] [Related]
40. On the estimation of local effective perfusion pressure in patients with obliterative arterial disease by means of external compression over a Xenon-133 depot. Nilsén R; Dahn I; Lassen NA; Westling H Scand J Clin Lab Invest Suppl; 1967; 99():29-30. PubMed ID: 6056929 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]